Navigation Links
Selling the nation's helium reserve
Date:1/20/2010

Helium is used in applications ranging from medical devices such as MRIs to surveillance balloons for national security. In the Helium Privatization Act of 1996, Congress directed the government to sell essentially all of the U.S. helium reserves by 2015 to compensate the government for its investment in the helium and its storage.

SELLING THE NATION'S HELIUM RESERVE, a new report from the National Research Council, assesses whether selling off the reserve has had any adverse effects on U.S. scientific, technical, biomedical, and national security users of helium. The report will be released at 11 a.m. EST on Friday, Jan. 22.


'/>"/>

Contact: Sara Frueh
news@nas.edu
202-334-2138
National Academy of Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Buying and selling habitats to help wildlife
2. Study: Smoking may worsen malnutrition in developing nations
3. Nations that sow food crops for biofuels may reap less than previously thought
4. ASM and FIND to partner on strengthening infectious disease diagnosis in developing nations
5. Nations and conservation groups seek plan to protect Ghost of the Himalayas
6. Global Biopact on biofuels can bring benefits to both rich and poor nations
7. Malfunction of the respiratory epithelium is a cause of allergy?
8. Scientists find amazing new pondlife on nature reserve
9. Case Western Reserve University grants option to startup Thermalin Diabetes Inc.
10. Longevity tied to genes that preserve tips of chromosomes
11. NJIT, US Marine Corps Reserve Association host counter-terrorism symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber ... announced it has led a $3.5 million investment in  ... platform. Strategic Cyber Ventures is DC based and is ... Hank Thomas . Ron Gula , also ... Ventures, also participated in this series A round of ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... and REYKJAVIK, Iceland , Feb. 28, ... group company and the contract genomics organization enabling precision ... Hannes Smarason has been appointed as the company,s chief executive ... and Alex Fowkes have been named chief ... "WuXi NextCODE is executing on its vision to enable anyone ...
(Date:2/28/2017)... 2017  Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical ... of autoimmune diseases, asthma and allergic diseases and ... quarter and full year ended December 31, 2016 ... business and clinical highlights. "During 2016, ... pipeline by starting five clinical trials across our ...
(Date:2/28/2017)... ... February 28, 2017 , ... The ... well as to their processing and transport properties. With the Litesizer™ 100 ... of samples. The Litesizer™ 100 gives rapid and accurate insight into particle systems, ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial Travel and ... 15 years of meeting this unique need within the biotechnology and pharmaceutical industries ...
Breaking Biology Technology: